- Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
- Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
- Relay Therapeutics to Participate in Upcoming Investor Conferences
- Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
- Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
- Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024
- Relay Therapeutics to Participate in Three Upcoming Investor Conferences
- Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
- Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024
- Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
More ▼
Key statistics
On Friday, Relay Therapeutics Inc (RLAY:NMQ) closed at 6.36, 11.58% above the 52 week low of 5.70 set on Apr 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.20 |
---|---|
High | 6.39 |
Low | 6.02 |
Bid | 6.00 |
Offer | 6.50 |
Previous close | 6.27 |
Average volume | 1.67m |
---|---|
Shares outstanding | 132.74m |
Free float | 129.60m |
P/E (TTM) | -- |
Market cap | 844.24m USD |
EPS (TTM) | -2.64 USD |
Data delayed at least 15 minutes, as of Jul 05 2024 21:00 BST.
More ▼